These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 27037639)

  • 1. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R; Bressington D; Hughes E; Ivanecka A
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review.
    Orsolini L; Chiappini S; Corkery JM; Guirguis A; Papanti D; Schifano F
    Expert Rev Neurother; 2019 Dec; 19(12):1253-1264. PubMed ID: 31503507
    [No Abstract]   [Full Text] [Related]  

  • 3. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
    [No Abstract]   [Full Text] [Related]  

  • 4. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.
    Neicun J; Yang JC; Shih H; Nadella P; van Kessel R; Negri A; Czabanowska K; Brayne C; Roman-Urrestarazu A
    PLoS One; 2020; 15(10):e0241056. PubMed ID: 33125395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic cathinones: a new public health problem.
    Karila L; Megarbane B; Cottencin O; Lejoyeux M
    Curr Neuropharmacol; 2015 Jan; 13(1):12-20. PubMed ID: 26074740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New/emerging psychoactive substances and associated psychopathological consequences.
    Schifano F; Napoletano F; Chiappini S; Guirguis A; Corkery JM; Bonaccorso S; Ricciardi A; Scherbaum N; Vento A
    Psychol Med; 2021 Jan; 51(1):30-42. PubMed ID: 31327332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Psychoactive Substances Toxicity: A Systematic Review of Acute and Chronic Psychiatric Effects.
    Taflaj B; La Maida N; Tittarelli R; Di Trana A; D'Acquarica I
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Growing Problem of New Psychoactive Substances (NPS).
    Madras BK
    Curr Top Behav Neurosci; 2017; 32():1-18. PubMed ID: 27571747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single chemical entity legal highs: assessing the risk for long term harm.
    McNabb CB; Russell BR; Caprioli D; Nutt DJ; Gibbons S; Dalley JW
    Curr Drug Abuse Rev; 2012 Dec; 5(4):304-19. PubMed ID: 23244343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel psychoactive substances (NPS) use in severe mental illness (SMI) patients: Potential changes in the phenomenology of psychiatric diseases.
    Bersani G; Prevete E
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New psychoactive substances of natural origin: A brief review.
    Feng LY; Battulga A; Han E; Chung H; Li JH
    J Food Drug Anal; 2017 Jul; 25(3):461-471. PubMed ID: 28911631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
    Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
    Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies.
    Assi S; Gulyamova N; Ibrahim K; Kneller P; Osselton D
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey.
    Simonato P; Corazza O; Santonastaso P; Corkery J; Deluca P; Davey Z; Blaszko U; Schifano F
    Hum Psychopharmacol; 2013 Jul; 28(4):324-31. PubMed ID: 23881880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical challenges of synthetic cathinones.
    Schifano F; Napoletano F; Arillotta D; Zangani C; Gilgar L; Guirguis A; Corkery JM; Vento A
    Br J Clin Pharmacol; 2020 Mar; 86(3):410-419. PubMed ID: 31674690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Psychoactive Substances (NPS) - a Challenge for the Addiction Treatment Services.
    Scherbaum N; Schifano F; Bonnet U
    Pharmacopsychiatry; 2017 May; 50(3):116-122. PubMed ID: 28444659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.
    Deligianni E; Daniel OJ; Corkery JM; Schifano F; Lione LA
    Br J Clin Pharmacol; 2020 Mar; 86(3):505-516. PubMed ID: 31495968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand.
    Rychert M; Wilkins C
    Int J Drug Policy; 2016 Nov; 37():90-97. PubMed ID: 27639994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of violence associated with novel psychoactive substance misuse in patients presenting to acute mental health services.
    Shafi A; Gallagher P; Stewart N; Martinotti G; Corazza O
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital.
    Tanti M; Cosgrove J; Kelleher C; Jones R; Maguire M
    Clin Med (Lond); 2021 May; 21(3):189-194. PubMed ID: 33947659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.